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Abstract
Research Questions
• In patients with chronic abdominal pain, flatulence, 
diarrhea and/or constipation, are providers missing the 
diagnosis of SID simply because they aren’t testing for 
it?  
• Are clinicians giving the broad diagnosis of IBS to 
patients who may have SID?  
• Should testing for SID be included in preliminary 








• Persistent gastrointestinal (GI) complaints are a common 
problem in patients presenting to family practice for care.
• Irritable bowel syndrome (IBS) is a diagnosis that adult 
patients are labeled with when clinicians have exhausted 
their differential list and no other cause of their GI 
symptoms can be confirmed.
• Sucrase-isomaltase deficiency (SID) has been historically 
shown to present early in life as a congenital disorder, but 
researchers are now recognizing occurrence later in life 
as a mild or secondary disorder.
• The literature emphasizes the disconcerting prevalence of 
sucrase-isomaltase deficiency (SID), the persistent 
symptoms associated with it, and the need for further 
research, especially in the adult population. 
• SID testing is cost effective, very reliable, and completely 
non-invasive
• It has been proven that after treatment of SID with 
sucrase replacement enzyme, patients were able to return 
to normal sucrose digestion and had resolution of their 
symptoms.
• Educating practitioners about SID and providing options 
for diagnosis and treatment are the first steps in helping 
the many patients that suffer from chronic bowel 
problems.
•Patients with an IBS diagnosis account for 
$1.7-10 billion in medical costs and an 
additional $10-20 billion of indirect costs in 
America annually (Cash & Chey, 2004).
•2.4-3.5 million yearly physician visits are 
specifically for patients with IBS symptoms 
(Cash & Chey, 2004).
•The variety of presentations and differing 
levels of severity of GI symptoms lead to 
many patients being misdiagnosed with a 
functional GI disorder (Puntis & Zamvar, 
2015).  
•The purpose of this scholarly project is to 
educate practitioners on the symptomology, 
the ease and low cost of diagnostic testing, 
and the treatment options for patients with 
SID.  
Pathophysiology of SID: 
• Sucrase-isomaltase (SI) is one of the main enzymes responsible for 
breaking down small starch units into glucose which then can be 
transported through the mucosal sodium dependent glucose 
cotransporter gate for utilization in the body (Lin, Hamaker, & 
Nichols, 2012). 
• When SI is not available or not functioning properly, a variety of 
adverse symptoms can occur. 
Comparing SID and IBS: 
• IBS is a functional disorder, one without physical or biological 
etiology, therefore, there aren’t any diagnostic studies that can be 
done to definitively diagnose it (El-Salhy, 2015). 
• Patients with either SID or IBS complain of diarrhea, abdominal 
pain, dyspeptic symptoms and worsening of these symptoms 
following eating (Puntis & Zamvar, 2015; Uhrich et al., 2012). 
Diagnosis of SID:
• Robayo-Torres et al. (2009) evaluated the sensitivity and 
specificity of 13C-breath tests in patients already confirmed to have 
CSID by duodenal biopsy.  Their results were encouraging, they 
found 100% specificity and 100% sensitivity for determining low 
sucrase activity by 13C-breath testing when comparing to 
duodenal biopsy
Treatment options for SID:
• Sucraid is the only FDA approved enzyme replacement available. 
In the study evaluating 13C- breath testing, the authors compared 
patient’s test values before and after initiation of Sucraid and 
found that patients were able to return to normal sucrose 
digestion with addition of Sucraid (Robayo-Torres et al., 2009). 
Up to 20% of adults experience 
unrelenting symptoms of abdominal pain 
and altered bowel habits and have not
been diagnosed with a cause (Eswaran et 
al., 2011). 
Once SID is confirmed, treatment is quite 
effective with all patients who were tested 
demonstrating full correction of SID 
symptoms with Sucraid supplementation 
and diet restriction (Robayo-Torres et al., 
2009).  
Practitioners can utilize the 13C-breath 
testing and subsequent Sucraid support 
and therefore improve the quality of life in 
10-20% of their patients with chronic 
abdominal problems. 
This could lead to a 10-20% reduction in 
patient and practitioner time as well as 
medical expense if SID testing was 
considered early.  
All practitioners should add SID to their 
differential diagnosis list and implement 
testing for their patients.  
I would like to give thanks to Professor Metzger 
and Professor Sieg for all their help in preparing 
this scholarly project.  I would also like to thank 
my family for all their support and 
encouragement during this program, it hasn’t 
been easy on them and they went above and 
beyond to help make this all possible.
Statement of the Problem
• Many patients suffer needlessly with sucrase-
isomaltase deficiency (SID) because clinicians are 
unfamiliar with and uneducated regarding this disease, 
its diagnosis, and its treatments. 
• More studies are needed to demonstrate the potential 
prevalence of SID in these misdiagnosed older 
patients and more clinicians need to be made aware 
of the possibility of SID as a true condition leading to 
chronic GI problems.
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Daileda et al. (2016) say it best, “the diagnosis 
of functional GI disease is usually made without 
evaluations of disaccharide activity, although 
symptoms from carbohydrate intolerance can 
overlap”. 
The focus has been directed at a way to more 
accurately, efficiently, and economically 
diagnose IBS, rather than testing for SID.
Symptoms of IBS and SID are similar in many 
ways, both are chronic and unrelenting and can 
include diarrhea, abdominal distention, bloating 
and abdominal pain. 
Nichols et. al. (2012) found that 9.3% of 30,334 
patients tested for disaccharidase deficiency 
were found to be sucrase deficient.  
El-Chamas, Williams and Miranda (2015) found 
37% of 203 patients evaluated for chronic 
abdominal pain were actually sucrase deficient. 
 Cohen (2016) cited several studies in his paper 
where the incidence of SID was found to range 
from 5-21% in patients, and disaccharidase 
deficiencies were found in 29.4% of patients 
presenting with GI symptoms.  
Daileda et. al. (2016) found in their meta-
analysis that 9% of 34,753 patients evaluated 
with EGD for possible disaccharidase 
deficiencies were sucrase deficient. 

13C-breath testing for SID is free to patients and 
the results are returned directly to the provider 
so follow up is guaranteed (Sucraid, 2016).  
The validity of the testing is excellent with 100% 
sensitivity and specificity (Robayo-Torres et al., 
2009). 
Nichols et al. (2012)
